Recruitment Matters

Diablo Clinical Research has a track record of meeting or exceeding recruitment goals and consistently ranks in the top five highest enrolling sites in multi-center trials over the last five years. Our strategic location and broad-based recruitment sources ensure we fill studies quickly and meet our sponsor requirements. 

Our recruitment scope of the entire bay area, plus outlying regions, includes 5.4 million people in a 6-county region. We have also built a large, detailed and diverse study patient database. Our media expertise and relationships means your clinical research project will be a success.

Recruitment Highlights:

  • 3 full-time recruitment specialists 
  • Patients pre-identified to ensure FPFV goal met
  • Consistently meet/exceed # patients enrolled & enrollment timelines
  • Average study retention rate of 98%
  • Ethnically diverse database with 16,000+ subjects
  • Wide range of recruitment avenues
    • Social Media/ Digital Advertising
    • Radio
    • Television 
    • Direct Mail 

Other Recruitment Services Include: 

  • Community Outreach 
  • On-site Seminars 
  • Health Fairs 
  • Volunteer Literature
  • Networking within local healthcare community 

Super-fast enrollment and treatment! We met our timeline faster than anticipated. Wonderfully organized site that was pleasant and a pleasure to work with. Thank you so much!” 

Physiowave

DCR Partner

Collaboration Matters

Diablo Clinical Research is an independent research site. Our dedicated research site has conducted over 900 studies involving potential new medications and devices for a variety of health conditions.

We provide top quality care for our patients and reliable data to our pharmaceutical sponsors.

Each research study we conduct is performed in accordance with the International Conference on Harmonization of Good Clinical Practice (ICH-GCP) and the Food & Drug Administration (FDA) standards.

“It has been an absolute pleasure working with DCR. Source, IP accountability, and eCRFs are always up to date and accurate. I cannot thank DCR enough for all their hard work.” 

Eli Lilly

DCR Partner

Investigator Oversight:

  • Minimum of 2 on site at anytime
  • Investigator participation in SQV, IM and SIV 
  • Train the coordinator on the indication/study
  • Review ICF and randomization criteria real time
  • Functions as the coordinator as necessary
  • Interactive relationship with Sponsor/Medical Monitor for each study

Regulatory Compliance:

  • Accurate and complete document submission/reporting to Sponsor/IRB 
    • Deviations
    • Unanticipated events
    • SAE reporting 
    • Staff qualifications
    • Study delegation
    • Training
  • ICF version control 
  • Archive/retention of essential documents

Document Management/Archiving:

  • TMF per study
    • Source document version control 
    • ICF document version control 
  • Onsite locked storage
  • Offsite long-term storage at Cor-O-Data
    • 24 hour document retrieval
  • Shred-It for confidential document disposal 
  • Computer backup in the cloud
           

  

Quality Matters

Our data is accurate: in the last 5 years we have had 5 FDA audits and 15 sponsor audits with no findings.

When searching for a research partner, quality is key. We ensure this by offering real-time review of first subject enrolled, 4 full-time QA/QC staff, annual and bi-annual trainings for ICH/GCP, SOP’s, ICF, and AE reporting. We also provide ICF version control, accurate and complete document submission/reporting to IRB, CRO and Sponsor and we handle the archiving/retention of essential documents.

“All documents filed in correct place. All drug accounted for in log. All source documents were prepared and completed. Study coordinator answers all e-mails in a very timely manner and ensures that all data is accurate and complete. Site is one of the top sites in the study.”

-CoLucid Pharmaceuticals, Inc.

DCR Partner

Annual and Bi-Annual Trainings:

  • Documented in employee files 
  • SOPs 
  • ICH/GCP
  • ICF, AE Reporting 
  • Continuous training on Protocol, ICF and Amendments  

QA/QC:

  • FT and project-based QA/QC staff 
  • 20% review per SOP; escalate as needed
  • Real-time review of 1st subject enrolled
  • Review of Sponsor DCFs
  • Works collaboratively with CRAs

Lab & Pharmacy:

     Lab:
  • Specimens packed/shipped/stored per lab manual/protocol 
  • Dry ice delievered 2x per week 
  • Samples are shipped via courier designated by protocol
  • Central or local labs or both
  • Locked and monitored refrigerators/freezers for storage
  • All temperature logs are archived on site
     Pharmacy:
  • Pharmacist on staff 
    • Study coordinator unless separate pharmacist required 
    • Unblinded staff include: Pharmacist or RN or MD as required
  • Access and Accountability 
    • Limited access via pharmacy access register
    • Full accountablity records maintained
  • Mixing
    • Laminar FlowHood for sterile mixing 

Facility Matters

Outpatient Unit (Phase 2-3)

  •   12,000 square feet
    • 3 exam rooms & 6 intake rooms
    • Lab/ draw area/ specimen collection 
    • Dedicated/separate workspace for monitors with copier and T1 wired and wireless access
    • 2 separate rooms for device studies
    • Large conference room
    • Offices for coordinators and MDs
    • Temperature controlled, keypad locked drug/device room with locked cabinets inside
    • Safe, dedicated parking lot
    • Alarm secured when not in use

Inpatient Unit (Phase 1, PK/PD, Extended Stay/Overnight):

  • 2,300 square feet
    • 6 beds, 4 infusion chairs, 2 bathrooms (1 with shower)
    • ACLS certified nurses and physicians
    • One common ward area
    • Lounge/kitchen area
    • Long, open hallways
    • Safe, dedicated parking lot
    • Alarm secured when not in use
    • Fire alarm alerts directly to fire department for 1st response
    • Dedicated/separate workspace for monitors with copier and T1 wired and wireless internet 
    • Games, magazines, puzzles, TV for patient entertainment

 
           

  

Areas of Expertise

Cardiovascular

Cholesterol/Lipids
Heart Disease Prevention
Hypertension/High Blood Pressure

Chronic Pain

Back Pain
Diabetic Peripheral Neuropathy
Fibromyalgia
Gout
Migraine
Osteoarthritis

Device Studies

Cardiovascular/Heart Disease
Diabetes
Healthy Volunteers

Endocrine/Metabolic 

Diabetes – Type 1 & Type 2
Diabetic Neuropathy
Metabolic Syndrome
Obesity/Weight Loss

Gastrointestinal 

Celiac Disease
IBS
Lactose Intolerance

Men’s Health

Erectile Dysfunction
Osteoporosis/Osteopenia

Vaccine

Avian Flu
CMV
HPV
Pneumococcal
RSV                                                     

      

Women’s Health

Female Sexual Dysfunction
Hot Flashes/Menopause
Osteoporosis/Osteopenia
Overactive Bladder/Incontinence

Partners in Research

Sponsors

Abbott Diabetes Care
Abbott Laboratories
Abbott Point of Care
Alkermes
Allergan
Alteon
Amgen
Amylin
Arkal Medical
Ascensia
Astellas
AstraZeneca
Axsome Therapeutics
Bayer Corporation
BD Diabetes Care
Biodelivery Sciences International
Biohaven Pharmaceuticals
Biomobie
BioSante/ANI
Boehringer Ingelheim
Bristol-Myers Squibb
Calibr-California Institute for Biomedical Research
Catabasis Pharmaceuticals Inc.
Cellegy
Chugai
Colucid Pharmaceuticals Inc.
Corcept
CPEX
Cypress
Daiichi-Sankyo
Dexcom
Diasome
Elcelyx Therapeutics Inc.
Eli Lilly
Esperion Therapeutics
FibroGen
Forest Labs
Forest Research Institute, Inc.
Gelesis
GlaxoSmithKline (GSK)
ImmusanT
Innovate Biopharmaceuticals
Insulet
Intarcia Therapeutics
iXensor Inc.
Janssen
JAZZ Pharmaceuticals
KOWA
Labopharm
Labrys Biologics
Lexicon Pharmaceuticals
Lexington Biosciences Inc.
LifeScan
Medibio Limited
Medtronic
Merck
Metabolex
Metabolic Solutions
Mylan
NeurogesX
Novavax
Novo Nordisk
NuPathe
Otsuka
Palatin Technologies
Pfizer
PhaseBio
Physiowave
Procter & Gamble
Proteus Digital Health
Provention
R2 Dermatology
Regeneron
REMD
Respirtech
Roche Diagnostics
Samumed
Sangamo
Sanofi
Senseonics
Solvay
Sonexa
Takeda
Tarsa Therapeutics
Teva
Transition Therapeutics
UC Davis
Versartis
ViroMed/HelixSmith
Xeris
XOMA

Partners in Research

CROs

Amarex
Beaufort CRO
Chiltern
Cognitive Research Corporation
Covance
ICON
IQVIA
Kendle International Inc.
MDS Pharma Services
Medpace
Paragon Bioservices
Parexel
PharmaNet
PPD
PRA Health Sciences
PRC Clinical
Premier Research
PSI
RCRI
Rho
SciRex
Syneos Health
Target Health, Inc.

Let’s Partner

5 + 15 =

Info

Address: 2255 Ygnacio Valley Road, Suite M Walnut Creek, CA 94598
Phone: (925) 930-7267
Fax: (925) 930-7392

Contact Us

2255 Ygnacio Valley Road, Suite M
Walnut Creek, CA 94598

(925) 930-7267

We Do More

Excellent Patient Healthcare: Diablo Clinical Research provides patients with high quality health care in a comfortable, professional, and confidential environment.

Valuable Study Data: Diablo Clinical Research provides sponsors with accurate and timely data to support new and improved therapies for a variety of health issues.

Community Service: Diablo Clinical Research provides free education and screening services to help the public stay informed about their health and well-being.

Do NOT follow this link or you will be banned from the site!